Rite Aid Corporation

OTCPK:RADC.Q 株式レポート

時価総額：US$2.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Rite Aid マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Jeffrey Stein

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間2.5yrs
取締役会の平均在任期間5.4yrs

経営陣の近況

Recent updates

Seeking Alpha • Oct 16

Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan

Summary Rite Aid File for Ch.11 bankruptcy on October 15. Under the plan shareholders get no recovery and shares will be cancelled. There is a stalking horse bid of $575 million for Elixir. Secured noteholders get 100% of the new equity. McKesson is trying to terminate their supply contract with Rite Aid. Read the full article on Seeking Alpha
Seeking Alpha • Jul 10

Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities

Summary Rite Aid's stock is being downgraded from "Hold" to "Sell" due to the opioid lawsuit, ongoing financial losses, and ineffective management. Rite Aid reported a $(5.56) net loss per share for 1Q. Elixir will discontinue their Medicare Part D program for individuals starting next year. The stock is effectively trading at only about $0.08 after adjusting for the 1-20 reverse stock split a few years ago. Read the full article on Seeking Alpha
Seeking Alpha • Jun 27

Rite Aid Q1 Earnings Preview: Bears Remain In Control

Summary Bears remain resolute in their strong bet against Rite Aid. Weak outlook from Walgreens hurt RAD stock ahead of the Q1 2024 report. Debt leverage and cost run rate remain a concern. Read the full article on Seeking Alpha
Seeking Alpha • Jan 09

Rite Aid names interim CEO as Heyward Donigan departs

Healthcare industry expert Elizabeth Burr has been elected as interim CEO at U.S. drugstore chain Rite Aid (NYSE:RAD), effective immediately. Burr, a member of the company’s board, will succeed president and CEO Heyward Donigan, who has left the company. She has extensive experience in the health industry, having previously served as VP, Head of Health Ventures and Chief Innovation Officer at Humana. The firm has initiated a search to identify a permanent CEO and has retained a leading executive search firm. In addition, Rite Aid (RAD) reiterated its fiscal 2023 financial guidance for total revenues of $23.7B and $24B vs. $21.63B consensus, net loss between $584M and $551M, adjusted EBITDA between $410M and $440M and capital expenditures of ~$225M. RAD shares gained 2% in Monday's premarket session
Seeking Alpha • Dec 20

Rite Aid Q3 2023 Earnings Preview

Rite Aid (NYSE:RAD) is scheduled to announce Q3 earnings results on Wednesday, December 21st, before market open. The consensus EPS Estimate is -$0.31 and the consensus Revenue Estimate is $5.94B (-4.7% Y/Y). Over the last 2 years, RAD has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 1 downward.
Seeking Alpha • Nov 15

Rite Aid spikes 20% on above average volume

The beaten-down pharmacy retailer Rite Aid Corporation (NYSE:RAD) climbed ~20% Tuesday on above-average volume, rallying alongside a buoyant broader market. About 3.0M Rite Aid (RAD) shares have changed hands compared to the 65-day average volume of ~2.6M. However, with its stock continuing to trade ~48% below the year-ago level, Rite Aid (RAD) shares have yet to surpass the mid-September levels. About 18% of the company’s float represents short interest. The rally coincides with gains in the major indices after Walmart (WMT) topped Street forecasts with its Q3 2022 results, and data on producer prices indicated signs of moderating inflation. Wall Street has remained bearish on Rite Aid (RAD) stock, with an average rating of Strong Sell from analysts. However, the Seeking Alpha Author ratings identify RAD as a Hold alongside SA’s Quant System, which consistently beats the market.
Seeking Alpha • Oct 11

Rite Aid partners with Google Cloud on pharmacy insights, customer engagement

Rite Aid (NYSE:RAD) has brokered a partnership with Google Cloud (NASDAQ:GOOG) that will provide the drug store chain with improved insights and customer experiences, as well as access to the Anthos platform for application deployment. Anthos will provide Rite Aid's (RAD) pharmacies with cloud computing capabilities on-site. In addition, it will support a vaccine scheduling tool, customer messaging infrastructure, and digital engagement platform. Rite Aid (RAD) will also benefit from Google Cloud's (GOOG) Retail Search product that provides customers with precise search results when shopping on the company's website. Also, Rite Aid (RAD) will migrate its enterprise data to Google Cloud (GOOG) using BigQuery which will provide improved insights into its finances, supply chain inventory, and customer information, powering data-driven decisions for its business operations. Check out why Seeking Alpha contributor WYCO Researcher rates Rite Aid (RAD) a hold.

CEO

Jeffrey Stein (55 yo)

less than a year
在職期間

Mr. Jeffrey Scott Stein is Chief Executive Officer and Chief Restructuring Officer at Rite Aid Corporation since October 16, 2023 and its Director since August 2024. He serves as Chief restructuring office...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Matthew Schroeder
CFO & Executive VP5.5yrsUS$2.75m0.36%
$ 7.8k
Jeffrey Stein
CEO, Chief Restructuring Officer & Directorless than a yearデータなしデータなし
Steven Bixler
Chief Accounting Officer & Senior VP1.7yrsデータなし0.0065%
$ 141.5
Byron Purcell
Vice President of Investor Relations & Treasurerno dataデータなしデータなし
Christin Bassett
Acting General Counsel & Corporate Secretaryless than a yearデータなしデータなし
Joy Seusing
Senior VP & Chief Communications Officerno dataデータなしデータなし
Jeanniey Walden
Senior VP & CMO1.5yrsデータなしデータなし
Jessica Kazmaier
Executive VP5.5yrsデータなし0.16%
$ 3.6k
Karen Staniforth
Senior VP of Clinical Pharmacy Services & Chief Pharmacy Officer2.5yrsデータなしデータなし
Angele Robinson-Gaylord
Senior Vice President of Store Development3.9yrsデータなしデータなし
Christopher DuPaul
Executive Vice President2.7yrsデータなし0.063%
$ 1.4k
2.5yrs
平均在職期間
54yo
平均年齢

経験豊富な経営陣: RADC.Qの経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Jeffrey Stein
CEO, Chief Restructuring Officer & Directorless than a yearデータなしデータなし
Robert Knowling
Independent Director5.9yrsUS$264.55k0%
$ 0
Arun Nayar
Independent Director5.9yrsUS$270.00k0.000050%
$ 1.1
Bruce Bodaken
Independent Chairman of the Board11.3yrsUS$425.00k0.012%
$ 258.6
Elizabeth Burr
Director5.4yrsUS$858.46k0%
$ 0
Carrie Teffner
Directorless than a yearデータなしデータなし
Paul Keglevic
Directorless than a yearデータなしデータなし
Bari Harlam
Independent Director4yrsUS$272.63k0%
$ 0
Katherine Quinn
Independent Director5.4yrsUS$283.75k0%
$ 0
5.4yrs
平均在職期間
62yo
平均年齢

経験豊富なボード: RADC.Qの 取締役会 は 経験豊富 であると考えられます ( 5.4年の平均在任期間)。

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2024/09/03 16:55
終値2024/09/03 00:00
収益2023/09/02
年間収益2023/03/04

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Rite Aid Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16

アナリスト機関
Steven ValiquetteBofA Global Research
William FrohnhoeferBTIG
George HillDeutsche Bank